Enphase Energy has drawn a consensus rating of “Reduce” from 31 research firms currently covering the company. Of those, ten analysts carry sell recommendations, fourteen recommend holding the stock and seven see it as a buy. The average 12-month price target stands at $41.09. Notable recent revisions include Zacks Research trimming its outlook from strong-buy to hold, Morgan Stanley lowering its objective from $28 to $26 with an underweight stance, TD Cowen cutting its target from $40 to $35 and Northland Securities boosting its objective from $52 to $62 while maintaining an outperform rating. Loop Capital also set a $31 target in its latest note.

Director Thurman J. Rodgers sold 150,000 shares at an average price of $29.13 for proceeds of approximately $4.37 million, reducing his stake by 7.96% to 1,733,596 shares (valued at about $50.5 million). In contrast, CEO Badrinarayanan Kothandaraman acquired 5,000 shares at $30.69 per share for a total of $153,450, modestly increasing his holding to 1,635,632 shares (roughly $50.2 million), a 0.31% rise. Insider ownership now accounts for 3.10% of the company’s outstanding stock, underscoring mixed sentiment at the management level.

Large funds have reshaped their Enphase stakes in recent quarters. Invesco Ltd. added 1,479,153 shares in Q2, lifting its total to 6,743,674 shares worth $267.4 million, a 28.1% increase. Geode Capital Management bought 73,459 additional shares (up 2.1%) to reach 3,542,878 shares valued at $140.2 million. In Q3, Coatue Management nearly doubled its position with an extra 803,945 shares, bringing its total to 1,647,893 shares ($58.3 million), while Federated Hermes increased its stake by 9.6% to 1,619,109 shares ($57.3 million). First Trust Advisors added 49,745 shares (up 5.0%), holding 1,050,158 shares worth $37.2 million. Overall, institutional investors now control 72.12% of the company’s stock.